Expert Speaker Faculty

Meet the visionaries shaping the future of ALS & FTD care at the 5th ALS Drug Development Summit.

Pharma Powerhouses Driving Neuromuscular Innovation
Biotech Trailblazers Transforming ALS & FTD Therapeutics
Investors, Advocates & Strategic Voices
Academic Titans & Clinical Thought Leaders
CRO Innovators Accelerating CNS Research

Pharma Powerhouses Driving Neuromuscular Innovation

Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation AbbVie- Expert Speaker at the 5th ALS Drug Development Summit 2026

Murali Gopalakrishnan

Global Head, Neuroscience Search & Evaluation, Corporate Strategy
Abbvie
Joyce Lo, Associate Director Biogen - Expert Speaker at the 5th ALS Drug Development Summit 2026

Joyce Lo

Associate Director
Biogen
Yunfeng Huang, Principal Scientist, Biogen - Expert Speaker at the 5th ALS Drug Development Summit 2026

Yunfeng Huang

Principal Scientist
Biogen
Joel Schwartz, Scientific Director, Bristol Myers Squibb - Expert Speaker at the 5th ALS Drug Development Summit 2026

Joel Schwartz

Director, Scientific Digital Biomarkers Neuroscience Trc, R & Ed
Bristol Myers Squibb
Francisca Martinez-Raub Director Eli Lilly - Expert Speaker at the 5th ALS Drug Development Summit 2026

Francisca Martinez-Raub

Director
Eli Lilly & Co.
Yea Jin Kaeser-Woo, Senior Director, Eli Lilly - Expert Speaker at the 5th ALS Drug Development Summit 2026

Yea Jin Kaeser-Woo

Senior Director
Eli Lilly & Co.
Arti Patel, Principal Scientist II, Novartis - Expert Speaker at the 5th ALS Drug Development Summit 2026

Arti Patel

Principal Scientist - Neuroscience & Program Lead
Novartis AG
Ivan Nyarko-Danquah, Postdoctoral Fellow, Sanofi - Expert Speaker at the 5th ALS Drug Development Summit 2026

Ivan Nyarko-Danquah

Postdoctoral Fellow
Sanofi
Kelly Glajch, Scientific Director, Rare Neurology, Neuroscience Therapeutic Area Unit, Takeda - Expert Speaker at the 5th ALS Drug Development Summit 2026

Kelly Glajch

Scientific Director, Rare Neurology- Neuroscience Therapeutic Area Unit
Takeda Pharmaceutical
Makoto Tamura, Executive Director of NeuroDiscovery Lab, Mitsubishi Tanabe Pharma - Expert Speaker at the 5th ALS Drug Development Summit 2026

Makoto Tamura

Executive Director
Tanabe Pharma

Biotech Trailblazers Transforming ALS & FTD Therapeutics

Christopher Shaw, Chief Scientific and Clinical Advisor, AviadoBio - Expert Speaker at the 5th ALS Drug Development Summit 2026

Christopher Shaw

Chief Scientific & Clinical Advisor
AviadoBio
Sarah Knutson, Executive Director, Early Discovery, Rome Therapeutics - Expert Speaker at the 5th ALS Drug Development Summit 2026

Sarah Knutson

Senior Director - Early Discovery
Early Discovery ROME Therapeutics
Javier San Martin, CMO, Athira Pharma - Expert Speaker at the 5th ALS Drug Development Summit 2026

Javier San Martin

Chief Medical Officer
LeonaBio
Michael Thurn, Managing Director & CEO, Neurizon - Expert Speaker at the 5th ALS Drug Development Summit 2026

Michael Thurn

Managing Director & Chief Executive Officer
Neurizon
Mansuo Lu Shannon, Chief Scientific Officer, Ask Bio - Expert Speaker at the 5th ALS Drug Development Summit 2026

Mansuo Lu Shannon

Chief Scientific Officer
Prevail Therapeutics
Michael Hayden, Chief Executive Officer, Prilenia - Expert Speaker at the 5th ALS Drug Development Summit 2026

Michael Hayden

Chief Executive Officer
Prilenia Therapeutics B.V.
Sandy Hinckley, Vice President, Head of Discovery, Quralis - Expert Speaker at the 5th ALS Drug Development Summit 2026

Sandy Hinckley

Vice President, Head of Discovery
QurAlis Corp.
Irina Antonijevic, Chief Medical Officer, Trace Neuroscience - Expert Speaker at the 5th ALS Drug Development Summit 2026

Irina Antonijevic

Chief Medical Officer
Trace Neuroscience
George Apostol, Senior Vice President, Clinical Development, uniQure - Expert Speaker at the 5th ALS Drug Development Summit 2026

George Apostol

Clinical Development Head
uniQure

Investors, Advocates & Strategic Voices

Eloise Jarvis, Researcher, Beacon Intelligence - Expert Speaker at the 5th ALS Drug Development Summit 2026

Eloise Jarvis

Lead Analyst
Beacon Intelligence
Christian Rubio, Executive Director & Head of Development, EverythingALS - Expert Speaker at the 5th ALS Drug Development Summit 2026

Christian Rubio

Executive Director & Head of Development
EverythingALS
Hanxiong (Bear) Zhang, Associate, RA Capital Management - Expert Speaker at the 5th ALS Drug Development Summit 2026

Hanxiong (Bear) Zhang

Principal
RA Capital Management

Academic Titans & Clinical Thought Leaders

Collin Hovinga, Vice President of Rare and Orphan Diseases, Critical Path Institute (C-Path) - Expert Speaker at the 5th ALS Drug Development Summit 2026

Collin Hovinga

Vice President - Rare & Orphan Diseases
CPATH
Phil Wong, Professor of Pathology, John Hopkins Medicine - Expert Speaker at the 5th ALS Drug Development Summit 2026

Philip C. Wong

Professor - Pathology
Johns Hopkins University
Ruth Chia, Staff Scientist, National Institutes of Health (NIH) - Expert Speaker at the 5th ALS Drug Development Summit 2026

Ruth Chia

Staff Scientist
NIH
John Replogle, Postdoctoral Fellow, The National Institutes of Health - Expert Speaker at the 5th ALS Drug Development Summit 2026

John Replogle

Director
NIH

CRO Innovators Accelerating CNS Research

Matthew Mandeville, Senior Business Development Manager, BrainXell, - Expert Speaker at the 5th ALS Drug Development Summit 2026

Matt Mandeville

Applications & Business Development
BrainXell
Ignazio de Giovanni, Vice President, Scientific Affairs, Neurology, Evestia Clinical - Expert Speaker at the 5th ALS Drug Development Summit 2026

Ignazio Di Giovanna

Vice President- Scientific Affairs, Neurology
Evestia Clinical
Massimiliano Bianchi, Founder, President & Chief Executive Officer, Ulysses Neuroscience - Expert Speaker at the 5th ALS Drug Development Summit 2026

Massimiliano Bianchi

Founder, President & Chief Executive Officer
Ulysses Neuroscience
Showcase Your Work at the 5th ALS Drug Development Summit 2026
Explore the Agenda

Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 30+ expert speakers shaping the future of ALS & FTD

View Presentations & Speakers
Networking with Decision Makers at 5th ALS Drug Development Summit 2026
Partner With Us

Showcase your solutions, connect with decision makers, and position your company as the go-to provider in neuromuscular and neurodegenerative research

Explore Sponsorship Options
5th ALS Drug Development Summit 2026 Event Image
Join Biopharma Experts

Network with pharma, biotech, diagnostics, academia, consortia, and patient voices driving real-world adoption

Register Now